Application Deadline: February 28th, 2025
Applications are now open for the 2025 Investing in Africa i3 Program. i3 seeks to catalyze the development of early and growth stage ventures building data-driven products or services focused on the distribution of health products in Africa. The program target companies owned, led or operated by African citizens and produce products for African customers.
Requirements
01 / African Ownership & Focus
Companies must be African-owned, led, or operated and focused on serving African markets.
02 / Tech-Enabled & Data-Driven
Innovators must leverage technology and data to improve healthcare delivery or product distribution.
03 / Stage-Specific Innovators
Early-Stage: Companies in the early stages of development with a proven concept.
Growth-Stage: Companies with demonstrated traction and scaling potential.
Benefits
- Access to Markets: i3 connects healthtech start-ups with large healthcare organizations including governments, donors, and global health institutions to drive adoption of start-ups’ offerings and scale.
- Risk-Tolerant Finance: i3 provides grant funding of $50K for early-stage innovators and up to $225K for growth-stage innovators, to overcome barriers to partnerships with large healthcare organizations e.g. WHO pre-qualification and regulatory compliance.
- Partnership Readiness Support: i3 provides a roadmap to help innovators meet the requirements for partnering with major healthcare organizations.
- Bespoke Deal Facilitation: i3 helps innovators refine their strategic positioning and increase the likelihood of successful partnerships and deals with large healthcare organizations.
- Communications and Advocacy: i3 provides highly professionalized communications and advocacy, to amplify the work of African healthtech innovators in the global health landscape. Additionally, i3 works towards resolving key ecosystem barriers that impact healthtech innovation in Africa.
For More Information:
Visit the Official Webpage of the Investing in Africa i3 Program
